GHO Capital, CBC Group Combine to Form $21B Healthcare Investment Giant
London-based GHO Capital and Singapore-based CBC Group plan to merge in a deal that would…
GHO Capital, CBC Group Combine to Form $21B Healthcare Investment Giant
London-based GHO Capital and Singapore-based CBC Group plan to merge in a deal that would create what the firms describe as the “world’s largest dedicated healthcare investment firm.” GHO has $10.5 billion assets under management, and CBC has $10.8 billion in assets under management. The post GHO Capital, CBC Group Combine to Form $21B Healthcare…
How long do Europeans have to wait for new pharmaceuticals after EMA approval?
The answer is provided by EFPIA’s annual WAIT indicator (press release, report). First, we see a large decrease in the share of pharmaceuticals fully availbity, drive by a small increase in reduced availability but a much larger increase in the number of drugs that only have a limited availability. Specifically, Historically full availability was the…
Report: How Employers Can Better Manage GLP-1s for Adolescents
A new Nomi Health report found that GLP-1 use and spending among adolescents rose sharply from 2022 to 2025, raising concerns about future costs for self-insured employers. The post Report: How Employers Can Better Manage GLP-1s for Adolescents appeared first on MedCity News.
Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA
Engage Bio developed a platform technology that enables non-viral delivery of DNA to cells. The acquisition is the latest in a series of Eli Lilly deals that expand the pharmaceutical company’s pipeline and capabilities in genetic medicines. The post Eli Lilly Grows Again in Genetic Medicines, Buying Startup With a New Way to Deliver DNA…
MedCity Pivot Podcast: A Conversation About Interoperability with Particle Health’s CEO
Jason Prestinario talks about the state of healthcare interoperability today, while also addressing questions about the interoperability lawsuits he and others are involved in against Epic. The post MedCity Pivot Podcast: A Conversation About Interoperability with Particle Health’s CEO appeared first on MedCity News.
Assessing PEPFAR’s Health Spillover Effects Beyond HIV: An Update
This analysis updates prior work that assessed the association between PEPFAR investments and several health indicators, beyond HIV. It finds that PEPFAR continues to be associated with significant improvement in these broader health gains, suggesting a spillover effect beyond the program’s HIV focus.
Assessing PEPFAR’s Economic and Educational Spillover Effects: An Update
This analysis updates prior work that assessed the association between PEPFAR investments and economic and educational outcomes. It finds that PEPFAR continues to be associated with significant improvement in these broader areas, suggesting a spillover effect beyond the program’s HIV and health focus.
When the Referee Owns the Team — and Tennessee Changes the Rules
At the center of this issue is a simple question: should the entities responsible for managing prescription drug benefits also own the pharmacies that profit from those decisions? The post When the Referee Owns the Team — and Tennessee Changes the Rules appeared first on MedCity News.
How AI & CMS are Solving the $4 Trillion Healthcare Crisis
The message to the industry is clear: If your business model is optimized only for FFS, you are the legacy. The future of healthcare belongs to those who can trade hours spent for improved patient lives. The post How AI & CMS are Solving the $4 Trillion Healthcare Crisis appeared first on MedCity News.
Why Patient Engagement Is Clinical Trials’ Next Strategic Frontier
As decentralized trials reduce face time with participants, sponsor organizations that treat engagement as an afterthought will pay for it in dropout rates, missing data and failed endpoints. The post Why Patient Engagement Is Clinical Trials’ Next Strategic Frontier appeared first on MedCity News.
